PMC5320815_01
Chest X-ray revealed a left side pleural effusion
JNSBM-8-130-g001.jpg
PMC5320815_01_JNSBM-8-130-g001.jpg
F1
Chest X-ray showed the left side pleural effusion [Figure 1].
Chest computed tomography scan showed a loculated left pleural effusion with associated pleural thickening and adjacent atelectatic changes and no evidence of lymphadenopathy or parenchymal lung involvement
JNSBM-8-130-g002.jpg
PMC5320815_01_JNSBM-8-130-g002.jpg
F2
Chest computed tomography (CT) scan showed a loculated left pleural effusion with associated pleural thickening and adjacent atelectatic changes and no evidence of lymphadenopathy or parenchymal lung involvement [Figure 2].
Diffuse increased hepatic attenuation consistent with amiodarone hepatotoxicity
JNSBM-8-130-g003.jpg
PMC5320815_01_JNSBM-8-130-g003.jpg
F3
In addition, diffuse increased hepatic attenuation, with an average of 110 Hounsfield units (HU) (normal attenuation in the liver: 30-70 HU), was noted on the lower chest CT scan images, consistent with amiodarone hepatotoxicity [Figure 3].
Three months after amiodarone dose reduction and prednisone tapering, the patient was asymptomatic and a follow-up chest computed tomography scan showed significant improvement of the effusion
JNSBM-8-130-g004.jpg
PMC5320815_01_JNSBM-8-130-g004.jpg
F4
Three months after amiodarone dose reduction and prednisone tapering, the patient was asymptomatic and a follow-up chest CT scan showed significant improvement of the effusion [Figure 4].